{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:31Z","timestamp":1790735911915,"version":"4.1.0"},"reference-count":237,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In the tumor milieu of head and neck squamous cell carcinoma (HNSCC), distinct B cell subpopulations are present, which exert either pro- or anti-tumor activities. Multiple factors, including hypoxia, cytokines, interactions with tumor cells, and other immune infiltrating lymphocytes (TILs), alter the equilibrium between the dual roles of B cells leading to cancerogenesis. Certain B cell subsets in the tumor microenvironment (TME) exhibit immunosuppressive function. These cells are known as regulatory B (Breg) cells. Breg cells suppress immune responses by secreting a series of immunosuppressive cytokines, including IL-10, IL-35, TGF-\u03b2, granzyme B, and adenosine or dampen effector TILs by intercellular contacts. Multiple Breg phenotypes have been discovered in human and mouse cancer models. However, when compartmentalized within a tertiary lymphoid structure (TLS), B cells predominantly play anti-tumor effects. A mature TLS contains a CD20<jats:sup>+<\/jats:sup> B cell zone with several important types of B cells, including germinal-center like B cells, antibody-secreting plasma cells, and memory B cells. They kill tumor cells via antibody-dependent cytotoxicity and phagocytosis, and local complement activation effects. TLSs are also privileged sites for local T and B cell coordination and activation. Nonetheless, in some cases, TLSs may serve as a niche for hidden tumor cells and indicate a bad prognosis. Thus, TIL-B cells exhibit bidirectional immune-modulatory activity and are responsive to a variety of immunotherapies. In this review, we discuss the functional distinctions between immunosuppressive Breg cells and immunogenic effector B cells that mature within TLSs with the focus on tumors of HNSCC patients. Additionally, we review contemporary immunotherapies that aim to target TIL-B cells. For the development of innovative therapeutic approaches to complement T-cell-based immunotherapy, a full understanding of either effector B cells or Breg cells is necessary.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1233085","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:48:21Z","timestamp":1696520901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Jiantong","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika C.","family":"Betzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32025","article-title":"Validation of NRG oncology\/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials","volume":"125","author":"Fakhry","year":"2019","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"JCO"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13464","article-title":"NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion\u2014the differences and similarities","volume":"166","author":"Roe","year":"2022","journal-title":"Immunology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.immuni.2018.08.012","article-title":"B cells are the dominant antigen-presenting cells that activate naive CD4+ T cells upon immunization with a virus-derived nanoparticle antigen","volume":"49","author":"Hong","year":"2018","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.3.1501","article-title":"CpG-DNA aided cross-priming by cross-presenting B cells","volume":"172","author":"Heit","year":"2004","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.9.5233","article-title":"B lymphocytes participate in cross-presentation of antigen following gene gun vaccination","volume":"174","author":"Hon","year":"2005","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0006","article-title":"B-cell cross-presentation of autologous antigen precipitates diabetes","volume":"61","author":"Mari\u00f1o","year":"2012","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1512458","article-title":"B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies","volume":"8","author":"Schl\u00f6\u00dfer","year":"2019","journal-title":"OncoImmunology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2020.5042","article-title":"Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer","volume":"57","author":"Yamakoshi","year":"2020","journal-title":"Int J Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.017","article-title":"B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity","volume":"41","author":"Laumont","year":"2023","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/all.14763","article-title":"Regulatory B cells, A to Z","volume":"76","author":"Jansen","year":"2021","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12939","article-title":"Regulatory B cells in cancer","volume":"299","author":"Michaud","year":"2021","journal-title":"Immunol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","article-title":"CD19+IL-10+ regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4+ T cells to CD4+Foxp3+ regulatory T cells","volume":"53","author":"Zhou","year":"2016","journal-title":"Oral Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02535-6","article-title":"Adenosine-producing regulatory B cells in head and neck cancer","volume":"69","author":"Jeske","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"OncoImmunology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive mechanisms of regulatory B cells","volume":"12","author":"Catal\u00e1n","year":"2021","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10\u2013competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","article-title":"Effector and regulatory B cells in immune-mediated kidney disease","volume":"15","author":"Oleinika","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","article-title":"B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer","volume":"179","author":"Hollern","year":"2019","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41467-021-22300-2","article-title":"Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling","volume":"12","author":"Hu","year":"2021","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948489","article-title":"Transcriptional meta-analysis of regulatory B cells","volume":"50","author":"Dubois","year":"2020","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201920","article-title":"Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator\u2013activated receptor \u03b1","volume":"190","author":"Wejksza","year":"2013","journal-title":"JI"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"JI"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301829","article-title":"HIF-1\u03b1\u2013mediated upregulation of TASK-2 K + Channels augments ca 2+ Signaling in mouse B cells under hypoxia","volume":"193","author":"Shin","year":"2014","journal-title":"JI"},{"key":"B34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease","volume":"9","author":"Meng","year":"2018","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.110","article-title":"IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5 + B- and T-cell trafficking to tumor-conditioned media","volume":"93","author":"Pimenta","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.29","article-title":"Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells","volume":"112","author":"Ricciardi","year":"2015","journal-title":"Br J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41467-017-00452-4","article-title":"Tumor-associated B-cells induce tumor heterogeneity and therapy resistance","volume":"8","author":"Somasundaram","year":"2017","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40425-018-0451-6","article-title":"Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion","volume":"6","author":"Ye","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3680","article-title":"Regulatory B cells are induced by gut microbiota\u2013driven interleukin-1\u03b2 and interleukin-6 production","volume":"20","author":"Rosser","year":"2014","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.016","article-title":"The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production","volume":"34","author":"Matsumoto","year":"2011","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01884","article-title":"Regulatory B cells and its role in central nervous system inflammatory demyelinating diseases","volume":"11","author":"Ran","year":"2020","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1075112","article-title":"PD-L1 mediated the differentiation of tumor-infiltrating CD19 + B lymphocytes and T cells in Invasive breast cancer","volume":"5","author":"Guan","year":"2016","journal-title":"OncoImmunology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.09.026","article-title":"Regulatory B cells accelerate hepatocellular carcinoma progression via CD40\/CD154 signaling pathway","volume":"355","author":"Shao","year":"2014","journal-title":"Cancer Lett"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.915556","article-title":"The role of regulatory B cells in patients with acute myeloid leukemia","volume":"25","author":"Lv","year":"2019","journal-title":"Med Sci Monit"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-019-01095-1","article-title":"Atypical memory and regulatory B cell subsets in tumor draining lymph nodes of head and neck squamous cell carcinoma correlate with good prognostic factors","volume":"14","author":"Norouzian","year":"2020","journal-title":"Head Neck Pathol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5588","article-title":"CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.24","article-title":"Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu","volume":"7","author":"Zhang","year":"2017","journal-title":"Blood Cancer J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","article-title":"B cell\u2013derived IL35 drives STAT3-dependent CD8 + T-cell exclusion in pancreatic cancer","volume":"8","author":"Mirlekar","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14122","article-title":"Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD -1 high Breg cells","volume":"110","author":"Mao","year":"2019","journal-title":"Cancer Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"13083","DOI":"10.1038\/s41598-019-49581-4","article-title":"Increased regulatory B cells are involved in immune evasion in patients with gastric cancer","volume":"9","author":"Murakami","year":"2019","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111652","article-title":"Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer","volume":"384","author":"Hu","year":"2019","journal-title":"Exp Cell Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6519427","article-title":"Role of regulatory B cells in the progression of cervical cancer","volume":"2019","author":"Chen","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2015.52840","article-title":"Short communication Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer","volume":"2","author":"Qian","year":"2015","journal-title":"Cejoi"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4538-0","article-title":"Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients","volume":"37","author":"Wei","year":"2016","journal-title":"Tumor Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0710","article-title":"IL35 hinders endogenous antitumor T-cell immunity and responsiveness to immunotherapy in pancreatic cancer","volume":"6","author":"Mirlekar","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3450","article-title":"Interleukin 21\u2013induced granzyme B\u2013expressing B cells infiltrate tumors and regulate T cells","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discovery"},{"key":"B63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molimm.2020.01.008","article-title":"PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis","volume":"119","author":"Wu","year":"2020","journal-title":"Mol Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.intimp.2017.05.018","article-title":"Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation","volume":"49","author":"Mao","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100994108","article-title":"B regulatory cells and the tumor-promoting actions of TNF-\u03b1 during squamous carcinogenesis","volume":"108","author":"Schioppa","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59266","article-title":"Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice","volume":"121","author":"Horikawa","year":"2011","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0668-3","article-title":"BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis","volume":"38","author":"Das","year":"2019","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-producing B cells promote the development of pancreatic neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discovery"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154817","article-title":"Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3","volume":"125","author":"Michaud","year":"2020","journal-title":"Cytokine"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1413520","article-title":"A novel MDSC-induced PD-1\u2013PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties","volume":"7","author":"Shen","year":"2018","journal-title":"OncoImmunology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2017.09.045","article-title":"MicroRNAs 15A and 16\u20131 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors","volume":"154","author":"Liu","year":"2018","journal-title":"Gastroenterology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/srep12255","article-title":"Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth","volume":"5","author":"Ganti","year":"2015","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300606","article-title":"Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells","volume":"191","author":"Lee-Chang","year":"2013","journal-title":"JI"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxw007","article-title":"Mammary-tumor-educated B cells acquire LAP\/TGF-\u03b2 and PD-L1 expression and suppress anti-tumor immune responses","volume":"28","author":"Zhang","year":"2016","journal-title":"INTIMM"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 + T cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-4184","article-title":"Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L","volume":"73","author":"Bodogai","year":"2013","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1101\/gad.220202.113","article-title":"An IKK\u03b1\u2013E2F1\u2013BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence","volume":"27","author":"Ammirante","year":"2013","journal-title":"Genes Dev"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nature08782","article-title":"B-cell-derived lymphotoxin promotes castration-resistant prostate cancer","volume":"464","author":"Ammirante","year":"2010","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.4.475","article-title":"B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell\u2013defficient mice results in T helper cell type 1 deviation","volume":"192","author":"Moulin","year":"2000","journal-title":"J Exp Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900185","article-title":"Nonredundant roles for B cell-derived IL-10 in immune counter-regulation","volume":"183","author":"Madan","year":"2009","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3766","article-title":"Inhibitory effects of B cells on antitumor immunity","volume":"66","author":"Inoue","year":"2006","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"166607","DOI":"10.1016\/j.jmb.2020.07.019","article-title":"Interleukin 35 regulatory B cells","volume":"433","author":"Choi","year":"2021","journal-title":"J Mol Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.07.013","article-title":"Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases","volume":"26","author":"Egwuagu","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2012.04.003","article-title":"Crosstalk between TGF-\u03b2 signaling and the microRNA machinery","volume":"33","author":"Butz","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2013-02-482406","article-title":"Adenosine production by human B cells and B cell\u2013mediated suppression of activated T cells","volume":"122","author":"Saze","year":"2013","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/2326-6066.CIR-16-0304","article-title":"Differentiated state of initiating tumor cells is key to distinctive immune responses seen in H-rasG12V\u2013induced squamous tumors","volume":"5","author":"Podolsky","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat Commun"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1\u2013PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/eji.201444625","article-title":"Antitumor effector B cells directly kill tumor cells via the Fas\/FasL pathway and are regulated by IL-10: Cellular immune response","volume":"45","author":"Tao","year":"2015","journal-title":"Eur J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3077","article-title":"Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells","volume":"75","author":"Bodogai","year":"2015","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0240","article-title":"Myeloid-Derived Suppressive Cells Promote B cell\u2013Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma","volume":"7","author":"Lee-Chang","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s40425-019-0726-6","article-title":"Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells","volume":"7","author":"Hlad\u00edkov\u00e1","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"key":"B105","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1541-7786.MCR-17-0153","article-title":"HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers","volume":"16","author":"Koneva","year":"2018","journal-title":"Mol Cancer Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7090241","article-title":"A review of HPV-related head and neck cancer","volume":"7","author":"Kobayashi","year":"2018","journal-title":"JCM"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.04.009","article-title":"Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells","volume":"26","author":"Meier","year":"2007","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902999","article-title":"Intragraft th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection","volume":"184","author":"Deteix","year":"2010","journal-title":"JI"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100052","article-title":"Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of ROR\u03b3t and LTi cells","volume":"208","author":"Lochner","year":"2011","journal-title":"J Exp Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvt263","article-title":"M1 macrophages act as LT\u03b2R-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis","volume":"101","author":"Guedj","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181216","article-title":"Type I interferon induces CXCL13 to support ectopic germinal center formation","volume":"216","author":"Denton","year":"2019","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00312","article-title":"Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection","volume":"7","author":"Neyt","year":"2016","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002101","article-title":"PD-1+CXCR5\u2013CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma","volume":"9","author":"Li","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91487","article-title":"CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer","volume":"2","author":"Gu-Trantien","year":"2017","journal-title":"JCI Insight"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01830","article-title":"Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease","volume":"8","author":"Colbeck","year":"2017","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606697104","article-title":"Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid","volume":"104","author":"Furtado","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131737","article-title":"IL-17\u2013induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs","volume":"211","author":"Fleige","year":"2014","journal-title":"J Exp Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.678127","article-title":"B cell orchestration of anti-tumor immune responses: A matter of cell localization and communication","volume":"9","author":"Kinker","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13058-017-0864-z","article-title":"Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes","volume":"19","author":"Prabhakaran","year":"2017","journal-title":"Breast Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","article-title":"Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling","volume":"179","author":"Coppola","year":"2011","journal-title":"Am J Pathol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/srep00765","article-title":"12-chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy","volume":"2","author":"Messina","year":"2012","journal-title":"Sci Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-020-00092-3","article-title":"Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma","volume":"12","author":"Li","year":"2020","journal-title":"Int J Oral Sci"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4036-4","article-title":"Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma","volume":"37","author":"Wirsing","year":"2016","journal-title":"Tumor Biol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0019-5","article-title":"Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma","volume":"31","author":"Wirsing","year":"2018","journal-title":"Mod Pathol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12405","article-title":"Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers","volume":"271","author":"Dieu-Nosjean","year":"2016","journal-title":"Immunol Rev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13389","article-title":"Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value","volume":"199","author":"Li","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10788","article-title":"Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors","volume":"7","author":"Wood","year":"2016","journal-title":"Oncotarget"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.1.203","article-title":"The Ets protein Spi-B is expressed exclusively in B cells and T cells during development","volume":"184","author":"Su","year":"1996","journal-title":"J Exp Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/nature13803","article-title":"T\u2013B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction","volume":"517","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jaci.2010.09.007","article-title":"The germinal center reaction","volume":"126","author":"Gatto","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B139","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41467-018-03128-9","article-title":"Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4","volume":"9","author":"Lu","year":"2018","journal-title":"Nat Commun"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/nature12428","article-title":"Stability and function of regulatory T cells is maintained by a neuropilin-1\u2013semaphorin-4a axis","volume":"501","author":"Delgoffe","year":"2013","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.10159","article-title":"PLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesis","volume":"225","author":"Van Der Zwaag","year":"2002","journal-title":"Dev Dyn"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+tumor-infiltrating lymphocytes have an atypical CD27\u2013 memory phenotype and together with CD8+T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120252","article-title":"Stromal cells in chronic inflammation and tertiary lymphoid organ formation","volume":"33","author":"Buckley","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0697","article-title":"Role of B cells in responses to checkpoint blockade immunotherapy and overall survival of cancer patients","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"B149","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.oraloncology.2017.05.010","article-title":"Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer","volume":"70","author":"Broglie","year":"2017","journal-title":"Oral Oncol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"221ra13","DOI":"10.1126\/scitranslmed.3007323","article-title":"Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions","volume":"6","author":"Maldonado","year":"2014","journal-title":"Sci Transl Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.9.3174","article-title":"Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma","volume":"5","author":"Atanackovic","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0796","article-title":"A comprehensive expression analysis of cancer testis antigens in head and neck squamous cell carcinoma revels MAGEA3\/6 as a marker for recurrence","volume":"14","author":"Zamun\u00e9r","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"OncoImmunology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019330","article-title":"Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor igG antibodies","volume":"6","author":"Gilbert","year":"2011","journal-title":"PloS One"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0059","article-title":"Antibody-dependent cellular cytotoxicity activity of a novel anti\u2013PD-L1 antibody avelumab (MSB0010718C) on human tumor cells","volume":"3","author":"Boyerinas","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature14424","article-title":"Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity","volume":"521","author":"Carmi","year":"2015","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.014","article-title":"Revisiting the immunoglobulin intramolecular signaling hypothesis","volume":"37","author":"Bowen","year":"2016","journal-title":"Trends Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/19420862.2018.1522178","article-title":"Antigen binding allosterically promotes Fc receptor recognition","volume":"11","author":"Zhao","year":"2019","journal-title":"MAbs"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0339-x","article-title":"Landscape of B cell immunity and related immune evasion in human cancers","volume":"51","author":"Hu","year":"2019","journal-title":"Nat Genet"},{"key":"B162","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4049\/jimmunol.182.1.5","article-title":"The surprising discovery that TGF\u03b2 Specifically induces the igA class switch","volume":"182","author":"Stavnezer","year":"2009","journal-title":"J Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0081","article-title":"A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases","volume":"23","author":"Montfort","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3979","article-title":"Antigen receptor repertoire profiling from RNA-seq data","volume":"35","author":"Bolotin","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","article-title":"Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma","volume":"19","author":"Shi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0949","article-title":"CD86+ Antigen-presenting B cells are increased in cancer, localize in tertiary lymphoid structures, and induce specific T-cell responses","volume":"9","author":"Wennhold","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/nri3754","article-title":"Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell","volume":"14","author":"Kambayashi","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf7470","article-title":"Marginal zone B cells acquire dendritic cell functions by trogocytosis","volume":"375","author":"Schriek","year":"2022","journal-title":"Science"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5A0416-182R","article-title":"Antigen-presenting human B cells are expanded in inflammatory conditions","volume":"101","author":"Shimabukuro-Vornhagen","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1051922","article-title":"A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4C T cell receptor repertoire clonality","volume":"4","author":"Zhu","year":"2015","journal-title":"OncoImmunology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/2326-6066.CIR-17-0075","article-title":"Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non\u2013small cell lung cancer patients","volume":"5","author":"Bruno","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701269","article-title":"Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity","volume":"200","author":"Engelhard","year":"2018","journal-title":"JI"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat Commun"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/ni1029","article-title":"Priming of naive T cells inside tumors leads to eradication of established tumors","volume":"5","author":"Yu","year":"2004","journal-title":"Nat Immunol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092454","article-title":"Tumor masses support naive T cell infiltration, activation, and differentiation into effectors","volume":"207","author":"Thompson","year":"2010","journal-title":"J Exp Med"},{"key":"B178","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40425-018-0446-3","article-title":"Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients","volume":"6","author":"Truxova","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J Clin Invest"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br J Cancer"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPIXUYDVZ0RZ3G","article-title":"Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid structures in HER2-positive breast cancer treated with adjuvant trastuzumab","volume":"144","author":"Lee","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0029","article-title":"Distinct tertiary lymphoid structure associations and their prognostic relevance in HER2 positive and negative breast cancers","volume":"22","author":"Liu","year":"2017","journal-title":"Oncol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31298","article-title":"Hyperactive gp130\/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development: gp130\/STAT3 regulates TLSs in gastric cancer","volume":"143","author":"Hill","year":"2018","journal-title":"Int J Cancer"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-170120","article-title":"Tertiary lymphoid structures associate with tumour stage in urothelial bladder cancer","volume":"3","author":"Koti","year":"2017","journal-title":"Bladder Cancer"},{"key":"B185","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12885-015-1116-1","article-title":"Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients","volume":"15","author":"Figenschau","year":"2015","journal-title":"BMC Cancer"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099008","article-title":"B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer","volume":"9","author":"Meshcheryakova","year":"2014","journal-title":"PloS One"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","article-title":"Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis","volume":"32","author":"Lee","year":"2019","journal-title":"Mod Pathol"},{"key":"B189","article-title":"Chapter Four - Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers","volume-title":"Adv Immunol","author":"Becht","year":"2016"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-016-9813-y","article-title":"Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer","volume":"33","author":"Schweiger","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3847","article-title":"Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin","volume":"19","author":"Remark","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B192","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2013.639","article-title":"Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer","volume":"110","author":"Ward","year":"2014","journal-title":"Br J Cancer"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.05.640","article-title":"Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: Prognostic impact may depend on type of treatment and stage of disease","volume":"45","author":"Distel","year":"2009","journal-title":"Oral Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-292","article-title":"Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma","volume":"9","author":"Pretscher","year":"2009","journal-title":"BMC Cancer"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139905","article-title":"Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity","volume":"131","author":"No\u00ebl","year":"2021","journal-title":"J Clin Invest"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.793992","article-title":"Molecular, immunological, and clinical features associated with lymphoid neogenesis in muscle invasive bladder cancer","volume":"12","author":"Pagliarulo","year":"2022","journal-title":"Front Immunol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.03.006","article-title":"Application of PD-1 blockade in cancer immunotherapy","volume":"17","author":"Wu","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2016-000122","article-title":"The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches","volume":"1","author":"Economopoulou","year":"2016","journal-title":"ESMO Open"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98811","article-title":"Frameshift events predict anti\u2013PD-1\/L1 response in head and neck cancer","volume":"3","author":"Hanna","year":"2018","journal-title":"JCI Insight"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41467-017-01018-0","article-title":"Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers","volume":"8","author":"Ock","year":"2017","journal-title":"Nat Commun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2974","article-title":"Vaccine-induced intratumoral lymphoid aggregates correlate with survival following treatment with a neoadjuvant and adjuvant vaccine in patients with resectable pancreatic adenocarcinoma","volume":"27","author":"Zheng","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0027","article-title":"Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation","volume":"2","author":"Lutz","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti\u2013PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci Transl Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1444753","article-title":"Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy","volume":"22","author":"Amatore","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"B210","doi-asserted-by":"publisher","first-page":"e1322238","DOI":"10.1080\/2162402X.2017.1322238","article-title":"Tbet and IL-36\u03b3 cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment","volume":"6","author":"Weinstein","year":"2017","journal-title":"OncoImmunology"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2013.42","article-title":"Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells","volume":"20","author":"Chen","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2821","article-title":"Phase I trial of intratumoral injection of CCL21 gene\u2013modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8+ T-cell infiltration","volume":"23","author":"Lee","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.89","article-title":"Synthetic immune niches for cancer immunotherapy","volume":"18","author":"Weiden","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00767","article-title":"Tumor-associated tertiary lymphoid structures: gene-expression profiling and their bioengineering","volume":"8","author":"Zhu","year":"2017","journal-title":"Front Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201803322","article-title":"Nanoengineered immune niches for reprogramming the immunosuppressive tumor microenvironment and enhancing cancer immunotherapy","volume":"31","author":"Phuengkham","year":"2019","journal-title":"Adv Mater"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224600","article-title":"MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity","volume":"14","author":"Yarchoan","year":"2019","journal-title":"PloS One"},{"key":"B217","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.abb.2009.01.018","article-title":"Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms","volume":"486","author":"Athar","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.04.030","article-title":"Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells","volume":"364","author":"Wang","year":"2015","journal-title":"Cancer Lett"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319912","article-title":"Interleukin-1\u03b2-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte\u2013mediated immune suppression","volume":"70","author":"Takahashi","year":"2021","journal-title":"Gut"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100744","article-title":"Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity","volume":"3","author":"Mirlekar","year":"2022","journal-title":"Cell Rep Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3211","article-title":"B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade","volume":"26","author":"Kim","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1085147","article-title":"Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma","volume":"5","author":"Castino","year":"2015","journal-title":"Oncoimmunology"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy218","article-title":"Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)","volume":"29","author":"Cottrell","year":"2018","journal-title":"Ann Oncol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S317626","article-title":"CpG-based nanovaccines for cancer immunotherapy","volume":"16","author":"Chen","year":"2021","journal-title":"Int J Nanomed"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3836","article-title":"De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors","volume":"18","author":"Johansson-Percival","year":"2017","journal-title":"Nat Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz252.011","article-title":"Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC)","volume":"30","author":"Rischin","year":"2019","journal-title":"Ann Oncol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2259-0","article-title":"Association of IL-36\u03b3 with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer","volume":"68","author":"Weinstein","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01609","article-title":"Induction of tertiary lymphoid structures with antitumor function by a lymph node-derived stromal cell line","volume":"9","author":"Zhu","year":"2018","journal-title":"Front Immunol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.1038\/s41598-017-15924-2","article-title":"Systematic screening of chemokines to identify candidates to model and create ectopic lymph node structures for cancer immunotherapy","volume":"7","author":"Yagawa","year":"2017","journal-title":"Sci Rep"},{"key":"B230","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-020-02370-4","article-title":"Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer","volume":"18","author":"Ryan","year":"2020","journal-title":"J Transl Med"},{"key":"B231","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1053\/j.gastro.2017.08.045","article-title":"Association between inflammatory diet pattern and risk of colorectal carcinoma subtypes classified by immune responses to tumor","volume":"153","author":"Liu","year":"2017","journal-title":"Gastroenterology"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.026","article-title":"B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas","volume":"25","author":"Affara","year":"2014","journal-title":"Cancer Cell"},{"key":"B233","doi-asserted-by":"publisher","first-page":"96","DOI":"10.18632\/oncotarget.28354","article-title":"The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy","volume":"14","author":"Shao","year":"2023","journal-title":"Oncotarget"},{"key":"B234","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s40425-019-0710-1","article-title":"Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200","volume":"7","author":"Mahadevan","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B235","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-35582-1_8","article-title":"CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy","volume-title":"Tumor Microenvironment","author":"Liu","year":"2020"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01025-7","article-title":"MEK inhibitors for the treatment of non-small cell lung cancer","volume":"14","author":"Han","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010198","article-title":"Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy","volume":"9","author":"Degirmenci","year":"2020","journal-title":"Cells"}],"updated-by":[{"DOI":"10.3389\/fimmu.2023.1327795","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1233085\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:29:40Z","timestamp":1700699380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1233085\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":237,"alternative-id":["10.3389\/fimmu.2023.1233085"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1233085","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2023.1327795","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"article-number":"1233085"}}